Andrew Ryan Conery,Jennifer Andrea Mertz,Robert Joseph Sims, III,Richard C. Centore
申请号：
US15301770
公开号：
US20170027955A1
申请日:
2015.04.02
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Described herein are novel methods for treating subjects with a cancer which is not overexpressing at least one of BCL-xL, BCL-w, and BAD, and optionally further overexpressing BCL-2. Also provided herein are tools for determining and/or assessing, and for the administration of, cancer treatments involving BET bromodomain inhibitors, BCL-xL inhibitors, or combinations thereof.
